Lawmakers want to end tax exemption for pharma ads; Gottlieb warns of “hard decisions” at FDA if shutdown continues; Feds to allow drugmakers to develop over-the-counter naloxone.
Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
Court documents detail aggressive marketing of OxyContin; Walgreens partners with Microsoft on research; Allergan wants High Court to take up Restasis patent lawsuit.
Walmart pharmacies set to leave CVS network; Edwards Lifesciences settles patent dispute with Boston Scientific; Pfizer to cut 150 R&D jobs.
Hospitals required to post prices; Judge halts new rules on ACA birth control mandate; New global pharma association rules ban gifts to doctors.
Louisiana adopts ‘Netflix model’ to pay for hepatitis C drug; J&J raises prices; Drug pricing advocacy group launches ad campaign supporting Trump proposals.
Day three at JP Morgan Healthcare Conference; Sanders-Cummings drug-pricing bill introduced; First patient treated under Right to Try Law.
JP Morgan day two; Medical marketing spending reaches $30 billion; Lilly runs first ads directing patients to price information.
Take the MM&M/Deloitte Consulting Healthcare Marketers Survey; Day one at JP Morgan; Cancer deaths down by more than a quarter over 25 years.
J.P. Morgan Healthcare Conference begins; Lilly to acquire Loxo; AstraZeneca hires Baselga to lead oncology R&D.
FDA considers allowing apps to prescribe drugs; Payers expect drug prices to keep rising; Rite Aid could be delisted from stock exchange.
BMS to buy Celgene for $74b; MDC names executive committee; Takeda creates immuno-oncology cell therapy unit.
Drugmakers raise prices; Judge allows CVS-Aetna merger, with conditions; Democratic presidential hopefuls focus on drug-pricing.
J&J continues to deny Reuters’ allegations; Lawmakers express asbestos concerns to EPA; And the winner of the inaugural MM&M Holiday Contest is…
Drugmakers plan to raise prices in January; Altria takes 35% stake in Juul; Study: Americans continue to pack on the pounds.
